Publications

Recent progress in the development of the RTS,S malaria vaccine: Summary of the RTS,S symposium.

Ballou, WR; Alonso, P; Leach, A; SUTHERLAND, C; Polhemus, M; Moree, M;

2006

ICOPA XI: PROCEEDINGS OF THE 11TH INTERNATIONAL CONGRESS OF PARASITOLOGY (2006).

RTS,S/AS02A malaria vaccine does not induce parasite CSP T cell epitope selection and reduces multiplicity of infection.

Enosse, S; Dobaño, C; Quelhas, D; Aponte, JJ; Lievens, M; Leach, A; Sacarlal, J; GREENWOOD, B; Milman, J; Dubovsky, F; Cohen, J; Thompson, R; Ballou, WR; Alonso, PL; CONWAY, DJ; SUTHERLAND, CJ;

2006

PLoS clinical trials, (2006).1 1 10.1371/journal.pctr.0010005.

From genomics to surveillance, prevention and control: new challenges for the African meningitis belt.

Alonso, J-M; Bertherat, E; Perea, W; Borrow, R; Chanteau, S; Cohet, C; Dodet, B; GREENWOOD, B; LaForce, FM; Rouzic, EM-L; Teyssou, R; Ouedraogo-Traoré, R; Sow, I;

2006

Vaccine, (2006).24 20 10.1016/j.vaccine.2006.03.037.

Delaying the international spread of pandemic influenza.

Cooper, BS; Pitman, RJ; EDMUNDS, WJ; Gay, NJ;

2006

PLoS medicine, (2006).3 6 10.1371/journal.pmed.0030212.

A case-control study of protection against tuberculosis by BCG revaccination in Recife, Brazil.

Dantas, OM S; Ximenes, RA D A; De Albuquerque, MD F P M; Da Silva, NL C L; Montarroyos, UR; De Souza, WV; Pereira, TC C; Campelo, AR L; RODRIGUES, LC;

2006

The international journal of tuberculosis and lung disease, (2006).10 5

Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

Trunz, BB; FINE, P; Dye, C;

2006

Lancet, (2006).367 9517 10.1016/S0140-6736(06)68507-3.

Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.

Hatzifoti, C; Roussel, Y; Harris, AG; WREN, BW; Morrow, JW; Bajaj-Elliott, M;

2006

Helicobacter, (2006).11 2 10.1111/j.1523-5378.2006.00385.x.

The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 months.

Bennett, AR; GORAK-STOLINSKA, P; Ben-Smith, A; FLOYD, S; De Lara, CM; Weir, RE; Lalor, MK; Makamo, K; Msiska, GK; CRAMPIN, AC; FINE, PE M; DOCKRELL, HM; Beverley, PC L;

2006

Vaccine, (2006).24 14 10.1016/j.vaccine.2005.12.011.

The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children.

Hesseling, AC; Marais, BJ; Gie, RP; Schaaf, HS; FINE, PE M; GODFREY-FAUSSETT, P; Beyers, N;

2006

Vaccine, (2006).25 1 10.1016/j.vaccine.2006.07.020.

Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales.

Sutton, AJ; Gay, NJ; EDMUNDS, WJ;

2006

Vaccine, (2006).24 13 10.1016/j.vaccine.2005.11.055.